Skip to main content
Healthcare

Moderna mRNA vaccine almost halves the risk of skin cancer returning

Moderna mRNA vaccine almost halves the risk of skin cancer returning

Feed excerpt — reported by Nature

Nature, Published online: 23 October 2026; doi:10.1038/d41586-026-03417-0Long-awaited results from phase III trial show a huge benefit in treating treatment-resistant melanoma.

MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at Nature →

Original Source

This article was syndicated from Nature. All rights remain with the original publisher.